Aura Biosciences Inc.

NASDAQ: AURA · Real-Time Price · USD
6.73
-0.27 (-3.86%)
At close: Aug 15, 2025, 3:59 PM
6.85
1.78%
After-hours: Aug 15, 2025, 05:02 PM EDT

Aura Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a 2.06M 2.06M 2.06M 2.06M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
291K 604K 910K 943K 1.34M 1.33M 1.35M 1.35M 1.25M 1.25M 1.18M 1.08M 1M 904K 916K 686K 468K 268K
Gross Profit
n/a -313K -619K 1.11M 713K 726K 704K -1.35M -1.25M -1.25M -1.18M -1.08M -1M -904K -916K -686K -468K -268K
Operating Income
-51.04M -73.8M -96.11M -93.09M -88.37M -85.88M -83.02M -75.84M -73.39M -66.93M -60.3M -54.31M -47.15M -42.13M -35.25M -28.53M -23.27M -20.62M
Interest Income
4.29M 6.74M 9.43M 10M 9.72M 9.28M 8.59M 7.04M 5.54M 3.83M 1.84M 780K 302K 10K 10K 5K n/a 1K
Pretax Income
-101.25M -94.61M -86.81M -82.99M -80.5M -78.47M -76.27M -70.84M -68.22M -63.39M -58.76M -53.84M -46.77M -42.16M -35.25M -28.52M -23.32M -20.62M
Net Income
-101.38M -94.7M -86.92M -83.22M -80.69M -78.65M -74.1M -93.78M -91.01M -86.18M -83.88M -53.71M -46.8M -42.18M -35.25M -28.52M -23.32M -22.55M
Selling & General & Admin
23.09M 23.24M 22.51M 21.21M 20.08M 19.35M 19.43M 19.71M 19.41M 18.56M 18.06M 17.25M 15.02M 12.88M 10.09M 7.81M 6.06M 4.73M
Research & Development
85.59M 79.59M 73.3M 71.25M 69.64M 67.88M 65.23M 58.11M 53.98M 48.37M 42.24M 37.06M 32.13M 29.25M 25.16M 20.73M 17.21M 15.89M
Other Expenses
n/a n/a -32K -58K -63K -95K -76K -58K -60K -33K -20K -12K 47K 52K 52K 52K n/a n/a
Operating Expenses
108.4M 102.55M 95.52M 92.46M 89.72M 87.23M 84.67M 77.82M 73.39M 66.93M 60.3M 54.31M 47.15M 42.13M 35.25M 28.53M 23.27M 20.62M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 25K 38K 38K 42K 18K 6K 6K 2K
Selling & Marketing Expenses
n/a n/a -306K -630K -630K -630K -324K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
51.97M 74.73M 97.04M 93.09M 90.35M 87.86M 84.99M 77.82M 73.39M 66.93M 60.3M 54.31M 47.15M 42.13M 35.25M 28.53M 23.27M 20.62M
Income Tax Expense
1K 49K 113K 226K -165K -165K -2.52M 22.59M 22.79M 22.79M 25.12M -130K -33K 18K -6K -6K 51K n/a
Shares Outstanding (Basic)
58.02M 50.13M 49.65M 49.66M 49.55M 49.45M 44.44M 38.19M 37.86M 37.78M 31.85M 29.27M 29.25M 29.21M 28.01M 28.01M 19.57M 19.57M
Shares Outstanding (Diluted)
58.02M 50.13M 49.65M 49.66M 49.55M 49.45M 44.44M 38.19M 37.86M 37.78M 31.85M 29.27M 29.25M 29.21M 28.01M 28.01M 19.57M 19.57M
EPS (Basic)
-1.96 -1.9 -1.75 -1.73 -1.79 -1.86 -1.86 -2.67 -2.73 -2.71 -2.75 -1.86 -1.64 -1.63 -1.49 -1.32 -1.19 -0.96
EPS (Diluted)
-1.96 -1.9 -1.75 -1.73 -1.79 -1.86 -1.86 -2.67 -2.73 -2.71 -2.75 -1.86 -1.64 -1.63 -1.49 -1.32 -1.19 -0.96
EBITDA
-50.44M -72.88M -94.89M -91.83M -89.06M -86.59M -83.7M -76.53M -72.14M -65.68M -59.12M -53.23M -46.15M -41.23M -34.42M -27.7M -22.43M -19.79M
EBIT
-49.04M -71.8M -94.12M -93.09M -90.35M -87.86M -84.99M -77.82M -73.39M -66.93M -60.3M -54.31M -47.15M -42.13M -35.25M -28.53M -23.27M -20.62M
Depreciation & Amortization
604K 917K 1.22M 1.26M 1.34M 1.33M 1.35M 1.35M 1.25M 1.25M 1.18M 1.08M 1M 904K 916K 912K 926K 917K